Chronic Interstitial Cystitis Clinical Trial
Official title:
A Phase 1b, Multicenter, Open Label Study Evaluating Safety, Tolerability and Preliminary Efficacy of LiRIS® 400 mg in Women With Ulcerative Interstitial Cystitis
The purpose of the study is to evaluate if LiRIS 400 mg is safe and tolerable when administered to women with Interstitial Cystitis with Hunner's lesions, and to evaluate any change in the bladder or in IC symptoms, following LiRIS administration.
n/a
Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT03143920 -
Hyperbaric Oxygen Therapy for Inflammatory Conditions of the Urinary Bladder
|
Early Phase 1 | |
| Recruiting |
NCT06299683 -
Pain Type and Interstitial Cystitis/Bladder Pain Syndrome Treatment
|
N/A | |
| Not yet recruiting |
NCT04734106 -
Safety and Efficacy of Aloe Vera in the Management of the Symptoms of Interstitial Cystitis
|
Early Phase 1 | |
| Not yet recruiting |
NCT06013449 -
Efficacy of Pulsed Electromagnetic Field and Heparin/Bupivacaine Instillations
|
N/A | |
| Active, not recruiting |
NCT02858453 -
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
|
Phase 3 | |
| Completed |
NCT04275297 -
Optimizing Psychosocial Treatment of Interstitial Cystitis/Bladder Pain Syndrome
|
N/A | |
| Completed |
NCT05744908 -
Pentosan Polysulfate Treatment's Effectiveness
|
N/A | |
| Completed |
NCT02331472 -
The Efficacy of Urine Biomarker in Patient With Interstitial Cystitis/Painful Bladder Syndrome (Pilot Study)
|
||
| Completed |
NCT04540887 -
PEMF Therapy to Treat Interstitial Cystitis/Bladder Pain Syndrome
|
N/A | |
| Recruiting |
NCT05149573 -
Investigation of PEMF Therapy for Female Patients With IC/BPS
|
N/A |